|

Gemcitabine and nab-paclitaxel Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Abraxane, Gemzar

Pipeline

Phase 1/2: 1

Top Sponsors

  • Orion Corporation, Orion Pharma1

Indications

  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Mesothelioma1
  • Pancreatic Cancer1
  • Lung Cancer1
  • Cancer1

Irving, Texas1 trial

A 2-part Phase 1/2 Open-label Trial on ODM-212

NEXT Oncology

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.